Non-MALT marginal zone B-cell lymphomas: A description of clinical presentation and outcome in 124 patients

Blood

Volumn 95, Issue 6, 2000, Pages 1950-1956

  Berger, Françoise ^b   Felman, Pascale ^b   Thieblemont, Catherine ^b   Pradier, Thierry ^b   Baseggio, Lucille ^b   Bryon, Paul Andre ^b   Salles, Gilles ^b   Callet Bauchu, Evelyne ^b   Coiffier, Bertrand ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD23 ANTIGEN; CD5 ANTIGEN; CHLORAMBUCIL; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; LEUKOSIALIN; PREDNISONE; VINCRISTINE;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BONE MARROW; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL FEATURE; CYTOGENETICS; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

EID: 0034653928     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.6.1950     Document Type: Article

References (27)

1. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361.
2. Isaacson PG, Spencer J. Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology. 1987;11:445.
3. Pileri SA, Milani M, Fraternali-Orcioni G, Sabattini E. From the REAL classification to the upcoming WHO scheme: a step toward universal categorization of lymphoma entities? Ann Oncol. 1998;9: 607.
4. Jaffe ES, Harris NL, Diebold J, Muller-Hermelink HK. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: a progress report. Am J Clin Pathol. 1999;110:s8.
5. Isaacson PG, Matutes E, Burke M, Catovsky D. The histopathology of splenic lymphoma with villous lymphocytes. Blood. 1994;84:3828.
6. Schmid C, Kirkham N, Diss T, Isaacson PG. Splenic marginal zone cell lymphoma. Am J Surg Pathol. 1992;16:455.
7. Catovsky D, Matutes E. Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma. Sem Hematol. 1999;36:148.
8. Shaibani K, Sohn CC, Burke JS, Winberg CD, Wu AM, Rappaport H. Monocytoid B-cell lymphoma: a novel B-cell neoplasm. Am J Pathol. 1986;124:310.
9. Nathwani BN, Drachenberg MR, Hernandez AM, Levine AM, Sheibani K. Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma). Sem Hematol. 1999:36:128.
10. The Non-Hodgkin's Lymphoma Pathologic Ctassification Project: National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a Working Formulation for Clinical Usage. Cancer. 1982; 49:2112.
11. Lennert K, Feller AC. Histopathologie der Non-Hodgkin Lymphome (nach der acktulisierten Kiel-Klassifikation). Berlin, Germany: Springer Verlag; 1990.
12. Berger F, Felman P, Sonet A, et al. Nonfollicular small B-cell lymphomas: a heterogenous group of patients with distinct clinical features and outcome. Blood. 1994;83:2829.
13. Fisher RI, Dahlberg S, Nathwani BN, Banks PM, Miller TP, Grogan TM. A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study. Blood. 1995;85:1075.
14. Isaacson PG, Wotherspoon AC, Diss T, Pan LX. Follicular colonization in B-cell lymphoma of mucosa-associated lymphoid tissue. Am J Surg Pathol. 1991;15:819.
15. Dierlamm J, Pittaluga S, Wlodarska I, et al. Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features. Blood. 1996;87:299.
16. Dierlamm J, Michaux L, Wlodarska I, et al. Trisomy 3 in marginal zone B-cell lymphoma: a study based on cytogenetic analysis and fluorescence in situ hybridization. Br J Haematol. 1996; 93:242.
17. Sole F, Woessner S, Florensa L, et al. Frequent involvement of chromosomes 1,3,7 and 8 in splenic marginal zone B-cell lymphoma. Br J Haematol. 1997;98:446.
18. Isaacson PG. Gastrointestinal lymphoma. Hum Pathol. 1994;25:1020.
19. Thieblemont C, Bastion Y, Berger F, et al. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol. 1997;15: 1624.
20. Thieblemont C, Berger F, Dumontet C, et al. Mucosa-associated lymphoid tissue (MALT) lymphoma is a disseminated disease in one third of the patients: analysis of 159 patients. Blood. In press, 2000.
21. Jaffe ES, Harris NL, Diebold J, Muller-Hermelink HK. World Health Organization classification of lymphomas: a work in progress. Ann Oncol. 1998;9:25.
22. Callet-Bauchu E, Rimokh R, Tigaud I, et al. Dic(4-17)(p11;p11): a new recurrent chromosomal abnormality in chronic B-lymphoid disorders. Genes Chromosomes Cancer. 1996;17:185.
23. Coiffier B. Fourteen years of high-dose CHOP (ACVB regimen): preliminary conclusions about the treatment of aggressive-lymphoma patients. Ann Oncol. 1995;6:211.
24. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:157.
25. Peto R, Pike MC, Armitage PEA. Design and analysis of randomized clinical trials requiring prolonged observations of each patient, II: analysis and examples. Br J Cancer. 1977;35:1.
26. Cox J. Regression models and life-tables. J R Stat Soc. 1972;34:187.
27. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: a predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993;329:987.